Breast Cancer Trial, Recruiting NCT06601621 Sponsor: Jiuda Zhao Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06601621
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 75 years old who have a general health/activity level rated at 0–2 on a standard oncology scale (confirm with trial site)
  • People who have not yet had chemotherapy and are planned to receive at least 4 cycles of chemotherapy before or after surgery, possibly combined with targeted therapy
  • People whose blood counts, kidney function, and liver function fall within acceptable ranges as measured by blood tests (confirm specific values with trial site)
  • Women who have not yet reached menopause and are using appropriate contraception
  • People who are able to understand the study and complete questionnaires about their experience

Who may not be able to join:

  • People who have a fear of needles or an allergy to stainless steel needles
  • People currently diagnosed with a mental health condition such as major depression, obsessive-compulsive disorder, or schizophrenia
  • People with a history of autoimmune diseases, blood disorders, or organ transplantation, or who have been taking hormones or immune-suppressing medications long-term
  • People who also have a bleeding disorder or a thyroid condition
  • People who have a pacemaker implanted, or who are currently pregnant or breastfeeding
  • People who are planned to have radiation therapy during their upcoming chemotherapy cycle
  • People who currently have an active infection
  • People who have had acupuncture treatment within the last four weeks
  • People who have a known allergy to the drugs being used in the study
  • People who plan to use other Traditional Chinese Medicine treatments, such as herbal medicine, during their chemotherapy cycle

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jiuda Zhao
Registry
ClinicalTrials.gov
Start date
19 October 2024
Est. completion
31 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Differences in quality of life during the overall stage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov